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(57) 	 ABSTRACT 
A scaffold assembly and related methods of manufacturing 
and/or using the scaffold for stem cell culture and tissue 
engineering applications are disclosed which at leastpartially 
mimic a native biological environment by providing bio-
chemical, topographical, mechanical and electrical cues by 
using an electroactive material. The assembly includes at 
least one layer of substantially aligned, electrospun polymer 
fiber having an operative connection for individual voltage 
application. A method of cell tissue engineering and/or stem 
cell differentiation uses the assembly seeded with a sample of 
cells suspended in cell culture media, incubates and applies 
voltage to one or more layers, and thus produces cells and/or 
a tissue construct. In another aspect, the invention provides a 
method of manufacturing the assembly including the steps of 
providing a first pre-electroded substrate surface; electrospin-
ning a first substantially aligned polymer fiber layer onto the 
first surface; providing a second pre-electroded substrate sur-
face; electrospinning a second substantially aligned polymer 
fiber layer onto the second surface; and, retaining together the 
layered surfaces with a clamp and/or an adhesive compound. 
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ALIGNED AND ELECTROSPUN 	 at least two layers of substantially aligned, electrospun poly- 
PIEZOELECTRIC POLYMER FIBER 	 mer fiber having an operative connection for individual volt- 
ASSEMBLY AND SCAFFOLD 	 age application to each layer; seeding the assembly with a 
sample of cells suspended in cell culture media; incubating 
CROSS-REFERENCE TO RELATED 
	
5 for an effective time period; applying an effective voltage to 
APPLICATIONS 	 one or more layers; and recovering cells and/or a tissue con- 
struct. 
This patent application claims the benefit of U.S. Provi- 	 In yet another embodiment, the invention provides a 
sional Patent Application No. 61/286,484, filed Dec. 15, 	 method of manufacturing an assembly for tissue engineering 
2009. 	 10 and/or stem cell differentiation including the steps of provid- 
ing a first pre-electroded substrate surface; electrospinning a 
STATEMENT REGARDING FEDERALLY 
	
first substantially aligned polymer fiber layer onto the first 
SPONSORED RESEARCH AND DEVELOPMENT 	 surface; providing a second pre-electroded substrate surface; 
electrospinning a second substantially aligned polymer fiber 
This invention was made in part by employees of the 15 layer onto the second surface; and, retaining together the 
United States Government and may be manufactured and 
	
layered surfaces with a clamp and/or an adhesive compound. 
used by or for the Government of the United States of 
	
Additional objects, embodiments and details of this inven- 
America for governmental purposes without the payment of 	 tion can be obtained from the following detailed description 
any royalties thereon or there for. 	 of the invention. 
20 
BACKGROUND OF THE INVENTION 
	
BRIEF DESCRIPTION OF THE SEVERAL 
VIEWS OF THE DRAWING(S) 
Current scaffold designs and materials do not provide all of 
the appropriate cues necessary to mimic in vivo conditions for 	 FIG. 1 illustrates SEM micrographs of electrospun PVDF 
tissue engineering and stem cell engineering applications. It 25 after (a) non-woven image collected on a static plate without 
has been hypothesized that many biomaterials, such as bone, 	 auxiliary electrode use, (b) 1-2 seconds, (c) 5 minutes, (d) 15 
muscle, brain and heart tissue exhibit piezoelectric and fer- 	 minutes, (e) 30 minutes, (f) 45 minutes [magnification 500x 
roelectric properties. Typical cell seeding environments 	 (a,c,d,f), 100x (b), and 845x (e)]. 
incorporate biochemical cues and more recently mechanical 
	
FIG. 2 illustrates scaffolds fabricated from CP2 polyimide 
stimuli. However, electrical cues have just recently been 30 with (a) optical image of 4 layer aligned fibers [mag. I Ox], (b) 
incorporated in standard in vitro examinations. In order to 	 live/dead assay results on aligned fibers, (c) optical image of 
develop their potential further, novel scaffolds are required to 	 nonwoven fibers [mag. 10x], and (d) live/dead assay results 
provide adequate cues in the in vitro environment to direct 	 on nonwoven fibers. 
stem cells to differentiate down controlled pathways or 	 FIG. 3 illustrates SEM micrograph of a cell attached to the 
develop novel tissue constructs. A scaffold that provides elec-  35 surface of a CP2 fiber. 
trical stimuli in conjunction with biochemical and mechani- 	 FIG. 4 illustrates a schematic drawing of an exemplary 
cal cues will have a significant impact on the proliferation and 	 scaffold with PVDF fibers electrospun directly onto a pre- 
differentiation of stem cells and tissue constructs that can be 	 electroded surface. 
engineered. 	 FIG. 5 illustrates a schematic drawing of an assembly of 
40 four scaffold layers in a 0/90/+45/-45 configuration. 
BRIEF SUMMARY OF THE INVENTION 
DETAILED DESCRIPTION OF THE INVENTION 
In view of the foregoing, it is an object of the invention to 
provide a scaffold assembly andrelated methods of manufac-
turing and/or using the scaffold for stem cell culture and 45 
tissue engineering applications in order to at least partially 
mimic a native biological environment by providing bio-
chemical, topographical, mechanical and electrical cues by 
using an electroactive material. 
It is a related object of the invention to provide the ability 50 
for delivering electrical and mechanical stimuli through bio-
active fibers for stem cell tissue engineering. Potential appli-
cations include stem cell therapy treatment methods such as, 
for example, spinal cord disorders, autoimmune diseases, and 
Parkinson's disease. Potential applications also include, for 55 
example, tissue engineering constructs for myocardial inf-
arcts, blood vessels, and skin grafts. 
These obj ects are achieved by the present invention, which 
in one embodiment provides an assembly for tissue engineer-
ing and/or stem cell differentiation using electrical and/or 60 
mechanical stimuli through bioactive fibers comprising at 
least one layer of substantially aligned, electrospun polymer 
fiber having an operative connection for individual voltage 
application. 
In another embodiment, the invention provides a method of 65 
cell tissue engineering and/or stem cell differentiation, said 
method including the steps of providing an assembly having 
Stem cells have enormous therapeutic potential for treating 
a multitude of medical disorders such as Parkinson's disease, 
autoimmune diseases, and spinal cord injuries. An attractive 
feature of this therapy is the ability to inject the stem cells 
directly at the treatment location without the need for addi-
tional delivery mechanisms. Adult stem cells are currently 
used to treat leukemia and other blood and bone disorders and 
recently have been approved as a treatment strategy for myo-
cardial infarcts and degenerative joint disease. Human mes-
enchymal stem cells (hMSCs) are adult stem cells derived 
from bone marrow that have demonstrated remarkable mul-
tipotency through their ability to differentiate across germ 
layers. A great deal of research in this area has focused on 
their trans-differentiation potential and the ability to direct 
their differentiation to specific lineages. A key component 
influencing the differentiation fate of stem cells is the in vitro 
environment in which they are cultured for expansion. This 
environment is comprised of a multitude of factors with the 
fundamentals being the selection of media, 2-D vs. 3-D scaf-
folds, and material considerations. Several groups have iden-
tified key differences in employing media containing serum 
and that free of serum with varying results. The physical 
culture conditions, however, remain rather elusive with 
numerous variables to consider such as topography, spatial 
US 9,005,604 B2 
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dimensions, material chemistry and mechanical properties. 
Current scaffold designs and materials do not provide all of 
the appropriate cues necessary to mimic in vivo conditions. It 
has been hypothesized that many biomaterials, such as bone, 
muscle, brain and heart tissue exhibit piezoelectric and fer-
roelectric properties. Typical cell seeding environments 
incorporate biochemical cues and more recently mechanical 
stimuli, however, electrical cues have just recently been 
incorporated in standard in vitro examinations. In order to 
develop their potential further, novel scaffolds are required to 
provide adequate cues in the in vitro environment to direct the 
stem cells to differentiate down controlled pathways. A scaf-
fold that provides electrical stimuli in conjunction with bio-
chemical and mechanical cues will have a significant impact 
on the proliferation and differentiation of the stem cells. 
The primary objectives of this invention are twofold; first, 
to develop a novel scaffold that provides mechanical and 
electrical cues that more closely mimic the cells' native envi-
ronment (such as heart, brain, nerve, muscle) and second, to 
determine the influence of the scaffold on the differentiation 
potential of exemplary human mesenchymal stem cells. The 
inventive embodiments are segmented into four key parts; the 
first is the manufacture of aligned electroactive fibers that will 
provide the electrical and mechanical cues; the second is to 
create a 3-D structure from the aligned electroactive fibers 
and to design a scaffold that combines the 3-D aligned fiber 
architecture with electrical and mechanical stimulus capabil-
ity; the third part is to determine the effect of topography on 
exemplary human mesenchymal stem cells phenotypic devel-
opment by comparing 2-D vs. 3-D environments; and the 
fourth is to determine hMSC phenotypic development as a 
function of electrical and mechanical stimuli application. 
In at least one embodiment, the invention involves the 
fabrication of electroactive polymer fibers that may comprise 
aliened single fibers or fiber bundles that are substantially 
parallel to one another. Electrospinning was used to yield 
fibers that can exhibit crystalline structures in polar form due 
to the strong electric field. And since aligned fibers are crucial 
in directing stein cell differentiation, the electrospinning pro-
cess was modified to generate highly aligned electroactive 
fibers in situ using an auxiliary electrode to focus the electric 
field. For more details on an exemplary method and system 
for aligning fibers during electro spinning, please see applica-
tion Ser. No. 12/131,420, which has published as US 2009/ 
0108503 Al, which is herein incorporated by reference. 
One of the specific aims of this invention is to fabricate an 
exemplary scaffold that confirms the effect of topography and 
architecture on the differentiation of exemplar) hMSCs. Such 
a scaffold design has not been demonstrated previously and 
this invention is significant because topography is known to 
play a critical role in attachment differentiation and prolifera-
tion of hMSCs. Although hMSCs are discussed in detail, 
certain inventive embodiments include other types of stem 
cells, e.g. induced pluripotent and/or embryonic stem cells. 
Research performed by Yim and Hu et. al. demonstrated the 
significant influence topographical cues have in directing the 
differentiation of hMSCs. It was observed that hMSCs 
respond to features in the nanometer and micrometer range. 
The formation of the extracellular matrix has been shown to 
occur on the nanometer level making this an attractive dimen-
sion. Other groups have investigated the effect of surface 
chemistry on the attachment, proliferation and differentiation 
of hMSCs. Engler et. al. reported that a material's elastic 
modulus alone is capable of directing stem cell differentia-
tion. They found that collagen production was significantly 
reduced when hMSCs were cultured on a `soft' matrix com-
pared to a `hard' matrix intended to mimic the differences 
4 
between biomaterials such as the brain and bone. In addition 
to topography, the architecture contributes considerably to 
the overall success of the scaffold. A scaffold comprising a 
three dimensional environment more closely mimics native 
5 surroundings than one constructed from two dimensions. 
There are two predominant scaffold constructs that provide a 
three dimensional environment, gels and fibers. Gels pro-
duced from collagen, fibrin, gelatin, alginate, and more 
recently thermoresponsive polymers demonstrate differing 
to results compared to conventional two dimensional systems 
when used to culture hMSCs. Scaffolds fabricated from fibers 
with diameters ranging from nanometers to micrometers have 
also been investigated extensively as three dimensional con- 
15 structs. Interesting results have been observed with this type 
of environment. One study compared the effects of a three 
dimensional gel environment to a fibrous scaffold and found 
vastly differing results between the two. Another scaffold was 
designed to mimic native cartilage by employing a composite 
20 structure manufactured to emulate the mechanical properties. 
A key issue confronting three dimensional scaffolds to date is 
control over the porosity. Porosity is vital to the health and 
maintenance of the cells in culture. If the porosity is insuffi-
cient, the cells will not receive adequate nutrients and may 
25 undergo hypoxia. One way to prevent this is to use aligned 
fibers to control porosity. Aligned fibers have been investi-
gated extensively and shown to promote cell alignment and 
attachment due to their high surface to volume ratio. Studies 
suggest that a fibrous structure plays a fundamental role in the 
30 modeling of the extracellular matrix and overall gene expres-
sion. 
Some embodiments of the invention involve electroactive 
polymer fibers, and in preferred embodiments, the polymer 
fibers used are composed ofpolyvinylidene fluoride (PVDF). 
35 PVDF is a commercially available polymer used in a variety 
of areas ranging from aerospace, medical, and automotive to 
common household applications. It is a crystalline material 
capable of assuming four different phases (a, (3, y, 6) depend-
ing upon processing and post-processing conditions. The y 
4o and 6 phases are quite uncommon and will not be examined 
for this study. The most common form is the a-phase. The 
crystalline structure is in a trans-gauche (TGTG) configura-
tion. When the material is mechanically stretched its crystal-
line form is altered to assume an all-trans configuration, 
45 which renders it electroactive due to alignment of the dipoles 
present in the structure. Subjecting the mechanically 
stretched material to an electric field further increases the 
dipole alignment in the crystalline structure and enhances the 
electroactive properties. This highly polar form is classified 
5o as the R -phase and is the desired state due to its unique 
electroactive properties. Electroactive PVDF is in a class of 
materials that exhibit piezoelectricity, i.e. a mechanical strain 
is elicited with the application of a voltage and conversely, an 
electrical signal is produced with the application of a 
55 mechanical strain. It is also pyroelectric, exhibiting an elec-
tric charge as a function of temperature. This is typically 
referred to as ferroelectric. PVDF poses an exciting possibil-
ity for cell culture studies for at least two reasons. First, the 
piezoelectric properties of the R -phase allows for direct appli- 
60 cation of electrical and mechanical stimuli to the cells. Sec-
ond, its pyroelectric property resulting from an applied tem-
perature is novel. Thermally stimulated current (TSC) data 
indicates that PVDF generates a slight current equivalent to 
approximately 2.2E-10A/m2 when subjected to standard cell 
65 culture conditions of 37° C. This property was included in the 
analysis during the topographical portion of the study. PVDF 
has been considered for a wide range of biomedical applica- 
US 9,005,604 B2 
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tions such as sutures and surgical meshes due to its inert 	 offers boundless potential for improving the quality of life for 
chemistry and good biocompatibility. 	 millions of individuals, possibly even offering cures for dis- 
Exemplary human mesenchymal stem cells (hMSCs) have 	 eases previously unattainable. Hence, despite numerous 
generated an enormous amount of interest due to their mul- 	 obstacles, research into hMSCs for stem cell therapy remains 
tipotency, the fact that they are non-controversial and they do 5 robust. 
not form teratomas. hMSCs have demonstrated multipotent 	 Inventive materials selected included PVDF, which was 
potential through their ability to trans-differentiate. Several 	 selected for its unique electroactive properties and its poten- 
research groups have reported success in directing hMSCs to 	 tial for biocompatibility. A fluorinated polyimide, CP2, was 
differentiate into adipocytes, chondrocytes, osteoblasts, neu- 	 also selected and synthesized from 2,2'-Bis(3,4-dicarboyx- 
rons, cardiomyocytes and muscle. There is considerable io phenyl) hexafluorpropane dianhydride (6FDA) and 1,3-bis 
debate as to whether hMSCs actually trans-differentiate or are 	 (4-aminophenoxy)benzene (APB) and was included to com- 
coerced into specific lineages by fusion with mature cells 	 pare to the PVDF due to its potential for biomedical 
present in their surroundings. Research by Engler et. al. has 	 applications. The biocompatibility of electroactive PVDF 
provided additional clarification surrounding this highly con- 	 was verified by performing a live/dead assay and examining 
troversial topic with their discovery on the multipotent poten-  15 the metabolic activity compared to standard tissue cultured 
tial of hMSCs based on the modulus of the scaffold. Their 	 polystyrene (TCPS) and a polyimide, CP2. The cells demon- 
study revealed a passive response of the hMSCs to the 	 strated good spreading and morphology on both film surfaces. 
microenvironment which is presumed to be indicative of a 	 A WST-1 assay confirmed the metabolic activities of PVDF 
multipotent stem cell. 	 and CP2 were comparable to TCPS indicating good biocom- 
Although hMSCs trans-differentiation potential has 20 patibility between hMSCs and PVDF. Since the surface ofthe 
sparked a great deal of debate among the research commu- 	 material plays a critical role in the cell attachment and spread- 
nity, there is no dispute regarding the multipotent potential of 
	
ing, we analyzed the films for functional groups present, 
hMSCs and their ability to be considered for therapeutic 	 surface roughness, and surface energy. FTIR-ATR results 
applications. In fact, hMSCs are an ideal research line 	 indicated the presence of primary aliphatic OH functional 
because they are not controversial since, they are derived 25 groups for PVDF by the peaks present at 1066 cm-1 and 
from bone marrow and in many instances, they can be autolo- 	 –3600 cm-1. Aliphatic POOH functional groups were 
gous, eliminating immunorejection concerns. Embryonic 	 identified in the spectra for CP2 by the broad OH stretching 
stem cells, while undoubtedly pluripotent, have generated a 	 region from 2500-3500 cm-1 and peaks present at 1072 cm-1, 
significant degree of controversy primarily over sourcing. It 	 1239 cm-1 and 1720 cm-1. It has been reported that OH 
will be challenging for human embryonic stem cells to be 3o and —COOH functional groups play a significant role in cell 
considered for clinical applications in the near term for this 	 attachment and proliferation. Several research groups have 
reason and also because they are extremely difficult to con- 	 attempted to add these functionalities to their materials to 
trol, often giving rise to tumor formation. 	 enhance these features and promote proliferation. 
In order to direct stem cell differentiation in vitro, it is 	 Contact angle measurements were performed on each film 
necessary to provide the appropriate cellular cues and envi-  35 surface using media warmed to 37° C. and found to be 67.34° 
ronment. This includes biochemical, mechanical and electri- 	 for PVDF and 78.68° for CP2 at equilibrium indicating the 
cal signals that emulate the native cellular environment. Typi- 	 surfaces were hydrophilic. The surface energy was calculated 
cally, cells are seeded in a tissue culture treated polystyrene 	 based on the equilibrium contact angle observed and was 
dish and provided with biochemical cues to guide them down 	 found to be 34.91 dynes/cm for PVDF and 26.02 dynes/cm 
a specific lineage. This has demonstrated moderate success, 40 for CP2. These values are quite low for a hydrophilic material 
but does not emulate the cells native environment. Research- 	 however, the surface roughness is not included in the theo- 
ers have recently begun to investigate the effects of mechani- 	 retical equation although it contributes significantly to the 
cal properties on the growing cells. They have demonstrated 	 wettability of the surface. The average surface roughness for 
that providing a mechanical environment similar to a cell's 	 each material was found to be 0.069 µm for PVDF and 0.009 
native area contributes significantly to the lineage pathway 45 µm for CP2 indicating sufficient roughness to promote adhe- 
chosen. Another group of researchers has shown that provid- 	 sion at the cellular level. The results were illustrated with 
ing electrical signals to embryonic stem cells results in a 	 images obtained using an optical profilometer. 
much largernumber of cells exhibiting markers for a neuronal 
	
Several researchers have reported a significant reduction in 
pathway. In order for stem cell therapy to become viable, cells 	 electroactive properties over a period of time when exposed to 
must be harvested, dissociated into individual cells and 50 in vivo conditions. Therefore, an in vitro degradation study 
expanded ex vivo. Stem cells that can be differentiated into a 	 was performed on PVDF to ensure the material properties 
preferred lineage and expanded down that pathway possess 	 were not changed as a result of long term exposure to the 
the ability to provide great therapeutic potential for numerous 	 environment. 
health disorders, hMSCs are currently being considered for 	 The mechanical properties were measured on five PVDF 
treatment in Parkinson's disease and other neural disorders 55 samples and averaged over the degradation period. There was 
due to their demonstrated ability to trans-differentiate or by 	 very little change over the 28 day period with overall about 
creating a favorable environment through the release of 
	
4% difference between the baseline and the last day for the 
soluble factors. 	 ultimate break stress, 7% difference in the elongation and 
There are a multitude of neurological and immune disor- 	 about a 5% difference in the modulus. There was not a report- 
ders for which cures remain elusive in the research commu-  6o able difference in the piezoelectric properties over the 28 day 
nity despite society's best efforts. In order to treat these con- 	 period as indicated by the thermally stimulated current 
ditions, new methods and clinical treatments must be 	 method. 
considered. Technology has brought about substantial medi- 	 The electrospinning manufacturing process is a simple and 
cal advances through the introduction of state-of-the-art diag- 	 versatile process that can be used to fabricate micro and 
nostic equipment and the ever changing drug therapies avail-  65 nanofibers from polymer solutions and melts. The process has 
able. It is necessary to step around some of the current barriers 	 typically produced random nonwoven mats and was modified 
to treatment and examine new options. Stem cell therapy 	 for this study to develop aligned fibers for a more controlled 
US 9,005,604 B2 
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8 
architecture. The set-up incorporates an auxiliary electrode 	 plary hMSCs. In order to determine the effect of fiber mor- 
that creates a dipole field and directs the electrospun fiber to 	 phology on the culture of hMSCs, the inventors performed 
a collector without the typical whipping and bending insta- 	 cell culture studies on films of the same material to be exam- 
bilities observed in other systems. The fiber continues to be 	 ined in fiber form. Preliminary results from examining the 
pulled along the dipole field over time and can be directed at 5 cells after 7 days and 14 days in culture indicate advanced cell 
an angle due to the repositioning of the auxiliary electrode. 	 structure by the presence of intermediate filament vimentin. A 
SEM micrographs illustrated in FIG. 1 demonstrate the 	 strong presence of beta III tubulin (TU71), an early stage 
degree of alignment achieved for various time periods rang- 	 neuronal marker, was present for all of the materials and 
ing from 1 second to 45 minutes. 	 MAP2 was present in the group conditioned with retinoic acid 
The crystalline structure of PVDF aids in determining the io and PVDF. Retinoic acid has been identified as a chemical 
overall properties of the resulting polymer, specifically, the 	 agent that induces the neuronal lineage in culture. Reverse 
piezoelectric state. A common technique to induce the 	 transcriptase PCR was performed on mRNA extracted from 
R -phase is to subject the a structure to mechanical stretching 	 the samples after 7 days and 14 days in culture. Gel electro- 
and a high electric field which results in orientation of the 	 phoresis staining indicated the upregulation of Oct 4, a 
dipoles within the crystalline structure. Electrospinning 15 marker typically present in embryonic stem cells, for the CP2 
incorporates both of these features; first by mechanically 	 polyimide coverslip, coverslip with retinoic acid and TCPS 
drawing the fiber from the spinneret to the collector and 	 after 14 days in culture. Genes corresponding to C-kit were 
second by creating a strong electric field which the fiber is 	 present in PVDF and coverslip. All of the material samples 
expelled through. The results from electrospinning a pure 	 expressed SOX 9, an early marker for chondrycyte formation 
a-phase powder from a solution of 50150 DMF:Acetone indi-  20 and alpha-fetoprotein (AFP). AFP is a protein expressed dur- 
cate a transition to the R -phase occurred based on peak shifts 	 ing early endoderm development and has been shown to 
illustrated in the x-ray diffraction (XRD) diffractogram. 	 express in hMSCs during hepatocyte differentiation. PVDF 
When examining the material using XRD, there are two pri- 	 also indicated the upregulation of MAP2 after 14 days in 
mary peaks indicating the starting crystalline form is in the 	 culture. This indicates there may be something happening on 
alpha phase. A shift of 20 to 20.6° indicates 200/110 reflec-  25 the cell signaling level with PVDF, perhaps related to the 
tions of the R -phase whereas the two shoulder peaks at 	 pyroelectric behavior, since MAP2 is a gene expressed during 
20=18.25° and 19.8° represent the 020 reflection of the 	 neuronal development. The expression of both endoderm and 
a-phase. The peak around 20=26.63° is representative of the 	 mesoderm markers suggested a mixed population of cells 
a-phase. This peak was not present in any of the processed 	 present. Gel electrophoresis data for the 7 day films did not 
forms present in the diffractogram indicating a shift from the 3o readily express any of the genes the inventors probed for 
a-phase to the R -phase occurring. The electrospun nonwoven 	 although the housekeeping genes, beta actin and GADPH, 
PVDF showed a peak shift around 20=28.57° suggesting it 	 were clearly observed. 
has not fully transitioned to the (3-phase. An additional peak 	 In order to determine the effect of PVDF fibers on the 
around 20=36.14° represents the 200 plane and is another 	 culture of hMSCs, scaffolds were manufactured from both 
indicator that the R  structure has been formed. 	 35 CP2 polyimide and PVDF. The fibers were electrospun 
Fourier transform infrared spectroscopy (FTIR) with 	 directly onto rings to be used in culture and affixed using 
attenuated total reflectance confirmed the transition to the 	 cyanoacrylate. The fibers were deposited in a configuration to 
R -phase by a change in the vibrational bands characteristic of 	 allow the greatest degree of porosity while maximizing cell 
the a-phase at 615 cm-1, 766 cm-1 and 795 cm-1 and the 	 attachment. Three different aligned fiber configurations were 
presence of a vibrational band at 840 cm-1. Differential scan-  40 examined. The `standard' configuration was composed of 
ning calorimetry (DSC) results for the electrospun aligned 	 fibers having average diameters of approximately 8 µm, the 
fiber depicted a melting point of approximately 160° C. on the 	 `fine' sample fiber diameters were on the order of 1 µm and the 
first heat. Subsequent quenching and a second heat indicated 
	
`mixed' sample consisted of a basement layer of fine fibers 
a shoulder peak present at 155° C. and 160° C. which was 	 followed by three additional layers of standard sized fibers. 
indicative of the two crystalline phases present, further dem-  45 The lay-up was in a 0/90/+45/-45 arrangement for each 
onstrating the crystalline R -phase transformation. The melt- 	 sample type. A sample comprised of a nonwoven collection of 
ing temperature for the electrospun aligned fibers was lower 	 fibers was used to assess the impact of aligning the fibers. 
than that far thepoled film (165' C.). There are several factors 	 Initial studies examined the effect of this architecture by 
that may contribute to the slight decrease. The number of 	 performing live/dead assays on fiber scaffolds manufactured 
head-head and tail-tail chain configurations will play a role in 50 from CP2. 
the overall melting point as will the percent crystallinity and 
	
The results are illustrated in FIG. 2. It is apparent from the 
the amount of a-phase and R -phase present. The presence of 	 results, which indicated the presence of some dead cells, that 
a shoulder peak in the poled film and its absence in the pure 	 the nonwoven scaffold either did not allow the appropriate 
powder further signifies the presence of both phases. 	 nutrients to diffuse through the scaffold or that the cells could 
A modified Rheovibron was used to measure the d31 55 not penetrate the scaffold for proper attachment. The aligned 
piezoelectric constant of a fibrous mat electrospun from 	 fibers, although quite auto-fluorescent, provide a good envi- 
PVDF for 45 minutes. Gold electrodes were deposited on 	 ronment for cell culture as can be observed by the cell attach- 
both sides of the mat and measurements were performed by 	 ment along the length of the fibers and throughout the mul- 
applying a tensile load of 35 g and measuring the d31 constant 	 tiple layers. An SEM micrograph depicting a dehydrated cell 
as a function of frequency and temperature. Results were 6o attached to a CP2 fiber is illustrated in FIG. 3. Gel electro- 
obtained for frequencies at 1 Hz, 10 Hz, 20 Hz and 100 Hz 	 phoresis results indicated the presence of Sox 9, a marker for 
over a temperature range of 23° C. to 50° C. A value for d31 	 chondrocyte formation, for each of the CP2 fiber sizes and 
was obtained, thus validating the rationale that electrospun 	 architectures examined after 7 days in culture. Immunostain- 
aligned PVDF fibers are poled in-situ during the electrospin- 	 ing of CP2 aligned fibers for vimentin, actin and the nucleus 
ning process. 	 65 revealed a well organized cell. The cells showed substantial 
As discussed earlier, topography plays a significant role in 	 alignment along the fibers. The mixed fibers did not display a 
cell attachment, differentiation and proliferation of exem- 	 cell structure as organized as those observed on the standard 
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and fine fibers. The nucleus was much more elongated on the 
fine fibers compared to the standard fibers. This suggests the 
cell was sitting on top of the standard size fibers since they are 
roughly the same size and the cell was elongating and perhaps 
wrapping around the fine diameter fibers in order to attach. 
PVDF fibers were also electrospun onto rings, in the con-
figuration described above for CP2, and affixed with 
cyanoacrylate, cultured for 7 days and stained for vimentin, 
actin and the nucleus. The cells were observed with confocal 
microscopy to attach to the fibers. The nucleus was elongated 
along the length of the fiber illustrating the influence of topog-
raphy on the cell morphology. It was also observed that what 
appears to be two cells attached to different fibers bridged 
across the fibers to contact one another. 
In at least one embodiment of the invention, an assembly 
for tissue engineering and/or stem cell differentiation is pro-
vided using a 3-D scaffold to apply electrical stimuli. In one 
embodiment, at least several factors were considered in the 
design of the 3-D scaffold in order to apply electrical and 
mechanical stimulation. These included the geometry, sub-
strate, electroding, adhesive, clamp fixture and fiber deposi-
tion. An exemplary 3-D scaffold was designed such that 
PVDF fibers could be electrospun directly onto a pre-elec-
troded (FIG. 4) surface minimizing the potential for shorting 
by electroding the fibers post-processing. The plan in this 
instance was to manufacture four layers independently, place 
them in a 0/90/+45/-45 configuration (FIG. 5) and retain 
them with a specially designed clamp. This allowed for the 
direct stimulation of each layer independently. Cell culture 
studies were performed on the scaffolds with the application 
of voltage to each layer. 
Accordingly, each substrate layer was fabricated using 
KaptonTM polyimide (DuPont) by laser cutting a 28 µm sheet 
of film. Gold electrodes were evaporated on each substrate. 
Gold was chosen as the electrode material due to its inert 
properties and excellent biocompatibility. DevconTM silicon 
adhesive was used to glue the electrospun fibers to the elec-
troded substrates. Each layer was fabricated separately, glued 
and allowed to air dry for a minimum of 48 hours. The four 
separate layers were joined together using the silicon adhe-
sive and allowed to dry fora minimum of 48 hours prior to cell 
culture. 
A clamp was designed to hold the four layer scaffold con-
struct together and keep it suspended from the bottom surface 
and allow for each layer to be stimulated independently or 
simultaneously. A grooved portion provided space for the 
flexible leads to extend outside of the culture area and the top 
piece secured the scaffold together by fitting snugly into the 
grooved piece. The clamp was fabricated from acrylic poly-
mer resin using the stereolithography rapid protyping pro-
cess. 
In order to maintain the existing architecture for compari-
son purposes, a similar design will be employed with one end 
of the substrate fixed and the free end mechanically extended 
in order to strain the PVDF fibers. The substrate will be cut on 
each side in order to obtain direct straining of the fibers 
without the influence of the substrate. Mechanically straining 
the fibers will elicit an electrical signal that is expectedto have 
a significant impact on the differentiation and proliferation of 
the hMSCs over time. 
Exemplary human mesenchymal stem cells were obtained 
from Tulane University. A single male donor was used 
throughout the study to prevent donor-donor variables. 
hMSCs were cultured in alpha minimum essential medium 
(oLMEM) with L-glutamine, but without ribonucleosides or 
deoxyribonucleo sides (Invitrogen/GIBCO), containing 
16.5% fetal bovine serum, premium select, hybridoma quali- 
lied, not heat inactivated (PBS, Atlanta Biologicals), 200 mM 
in 0.85% NaCl of L-glutamine (Invitrogen/GIBCO), 100 
units/ml penicillin and 100 µg/ml streptomycin (Invitrogen/ 
GIBCO). Cell culture medium was filtered through a sterile 
5 filter unit. Cells were plated at an initial density of approxi-
mately 350 cells/cm2 in a 15 cm dish and incubated at 37° C. 
with humidified 5% COz . Media was replenished every three 
days. Cells were passaged after reaching approximately 80% 
confluence by aspirating media, washing 1 x with phosphate 
to buffered solution (PBS, Invitrogen) and lifting with 0.25% 
Trypsin and 1 mM ethylene diamine tetracetic acid (EDTA) in 
Hank's balanced salt solution (Invitrogen/GIBCO) for 1-3 
minutes at room temperature. After incubation in Trypsin/ 
15 EDTA, 5 ml of cell culture media was added and the mixture 
was transferred to a 15 ml conical centrifuge tube. The cells 
were centrifuged for 10 minutes at 450xg at room tempera-
ture. The supernatant was aspirated and the cell pellet resus-
pended in 1.0 ml cell culture media. Cells were counted by 
20 adding 10 µl 0.4% Trypan Blue solution to 10 ld of cell 
suspension and dispersing them onto a hemocytometer. Cells 
were seeded onto scaffolds between passages 2-5 at a density 
of approximately 125,000 cells/cm 2 . Attachment of the cells 
to the scaffold was promoted by seeding an initial volume of 
25 250 µl of cell suspension on each scaffold and allowing it to 
incubate at 37° C. with humidified 5% CO 2 for a minimum of 
one hour. After the initial incubation period, an additional 
volume of 3-4 ml of cell culture media was added to each well 
and the scaffold were placed back in the incubator at 37° C. 
30 with humidified 5% CO 2 for 7 days. Media was replenished 
every three days. Electrical leads clamped to the flexible leads 
of the scaffold were attached to a power supply and a 9 
mV/cm stimulus was applied to each scaffold layer after 
approximately 24 hours post-seeding at a frequency of 500 
35 mHz. 
In order to determine an exemplary minimum voltage 
required to cause an effect on the calcium channels, a pre-
liminary calcium imaging experiment was performed using a 
Fluo-4 NW (no wash) assay (Molecular Probes). PVDF and 
40 CP2 polyimide films were examined. Films were laser cut to 
provide a flexible lead and An electrodes were evaporated on 
the surface in order to attach wires to the substrates. hMSCs 
were seeded on PVDF and CP2 films at a density of 5000 
cells/cm2 and allowed to incubate for 24 hours at 37° C. in 
45 humidified 5% CO2. A 250 mM stock solution of probenicid 
was prepared by adding of assay buffer to probenicid and 
vortexing until dissolved. The dye loading solution was pre-
pared by adding 10 mL assay buffer and 100 µL probenicid 
stock solution to Component A and vortexing for 1-2 minutes. 
5o A 1 µM acetylcholine (AcH) (Sigma-Aldrich) sample was 
prepared in buffer. To prepare for imaging, media was 
removed from the wells and the samples were washed 2x with 
PBS. A volume of 1 mL, of dye loading solution was added to 
each sample and the samples were incubated at 37° C. in 
55 humidified 5% CO2 for 30 minutes. The samples were placed 
under an upright fluorescent microscope (Zeiss AxioOb-
server) fitted with a heated stage. Wires were attached to the 
flexible electrodes protruding outside of the chamber. The 
voltage supply (Keithley) was monitored using an oscillo- 
60 scope (Wavetek). Data were recorded for a period of 2 min-
utes prior to the application of stimuli. AcH was added after 
several minutes of baseline data collection and served as a 
positive control. Power was applied to the substrate and 
recorded for several minutes. Data was obtained and post- 
65 processed using Metamorph software (Zeiss). The average 
fluorescence intensity for a minimum of 7 cells was plotted as 
a function of time. 
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Results from the live cell calcium imaging study indicated 	 vimentin. The cells attached to multiple layers of the scaffold 
that application of 9 mV/cm of a direct current electric field 	 with the nuclei highly aligned along the fibers. Vimentin 
was sufficient to elicit a response in the cells. The addition of 	 appeared to be forming a network across the fibers similar to 
AcH showed a peak intensity of about 600 while the CP2 film 	 what was observed in the culture on CP2 and PVDF fibers. 
with 9 mV/cm direct current electric field applied had an 5 Neuronal markers MAP2 and TU71 were evident. 
intensity of around 1100, nearly two times the results 	 Western Blot was performed. Determining the protein con- 
obtained with AcH. The PVDF film peaked around 625, simi- 	 centration was performed. After 7 and 14 days in culture, 
lar to the results obtained using AcH to stimulate the Ca+ 	 protein was extracted from the cells attached to the scaffolds 
channels. Spontaneous Ca+ signals were observed in the 	 by placing the dish on ice, aspirating the media, washing 1 x 
PVDF film prior to the application of 9 mV/cm direct current 10 with PBS and adding 250 ld RIPA buffer (Pierce) containing 
electric field. 	 1:100 Halt Protease Inhibitor (PI, Pierce) cocktail (100 mM 
The proliferation of cells was analyzed using EdU Click- 	 AEBSF.HCl, 80lLMAprotinin, 5 mM Bestatin, 1.5 mM E-64, 
iTTM Imaging Kit (Invitrogen). Cell culture was performed as 	 2 mM Leupeptin, 1 mM Pepstatin A) to prevent protein deg- 
described above. Briefly, hMSCs were seeded on scaffolds 	 radation. The lysis buffer containing the extracted proteins 
and in a 6 well tissue culture dish at a density of 200,000 cells. 15 was transferred to a 2 ml microcentrifuge tube and stored at 
After 24 hours in culture, EdU was added to the media at a 	 —80° C. until use. The protein concentration was quantified 
concentration of 10 µM. After 3 days in culture, media was 	 using the bicinchoninic acid (BCA) kit (Pierce). A standard 
replenished with fresh media containing 10 µM of EdU. After 	 curve was generated using BSA. The Gel was prepared, 
7 days, the samples were removed, fixed with 4% PEA 
	
loaded and run. The protein sample containing 2x Laemmli 
(Sigma-Aldrich) for 15 minutes at room temperature then 20 buffer (Sigma-Aldrich) was heated at 95'C. for 5 minutes and 
washed 2x with PBS containing 3% bovine serum albumin 	 centrifuged briefly prior to loading. Polyacrylamide Ready 
(BSA, Sigma-Aldrich). After the wash was removed, the 	 Gels (Biorad) having a range from 5-20% and 30 µl wells 
samples were incubated for 20 minutes at room temperature 	 were placed in the electrophoresis chamber. The chamber was 
in 0.5% TritonX-100 in PBS. The reaction cocktail was pre- 	 filled with 1xSDS-PAGE running buffer consisting of Tris 
pared by mixing 1.8 mL 1 x Click-IT reaction buffer, 80 µL 25 base (25 mM, pH 6. 8), Glycine (192 mM) and SDS (0.1%) in 
CuSO4, 5 µL Alexa Fluor azide, and 200 µL reaction buffer 	 deionized water. The standard was made from Precision Plus 
additive. The permeabilization buffer was removed and the 	 Protein Kaleidoscope Standard (Biorad) and 5.5 µl was 
samples were washed 2x with PBS containing 3% BSA. The 	 loaded into the first well of each gel. 10 µg of protein was 
wash was removed and the Click-iT reaction cocktail was 	 loaded in the gel. The gel was run at 180 V for 55 minutes. The 
added to each sample. The samples were incubated for 30 30 Gel was transferred. The gel was removed and placed over a 
minutes at room temperature protected from light. The reac- 	 pre-wetted nitrocellulose transfer membrane. The gel and 
tion cocktail was removed and the samples were washed with 	 transfer membrane were assembled and placed in the cham- 
PBS containing 3% BSA. Each sample was washed with PBS 
	
ber with the gel facing the anode and membrane facing the 
prior to DNA staining. A Hoechst 33342 (1:2000) was added 	 cathode. An ice block was added to the chamber and it was 
to each sample and incubated for 30 minutes at room tern- 35 filled with transfer buffer consisting of Trisbase (25 mM), 
perature protected from light. The samples were washed 2x in 	 Glycine (192 mM) and Methanol (20%). The set-up was 
PBS and mounted to coverslip with gel mount (Invitrogen). 	 transferred to the cold room and run for 90 minutes at 80 V. 
The samples were imaged using confocal microscopy. A 
	
Primary and Secondary Antibodies were added. A 100 ml 
minimum of 400 cells were counted. 	 solution of 5% nonfat milk (Biorad) in 1 xTBS (50 mM Tris 
Proliferation results for the PVDF fiber stimulated scaffold 40 pH 8.0, 150 mM NaCI) containing 0.1% Tween 20 (Sigma- 
and TCPS indicated the stimulated scaffold had 10% greater 	 Aldrich) was prepared for blocking. The transfer membrane 
incorporation of EdU compared to TCPS, with 33% EdU- 	 was removed from the chamber, stained with Ponceau S non- 
positive cells in the stimulated fiber scaffold compared to 	 specific protein stain (Sigma-Aldrich) and cut using a razor 
23% on TCPS. 	 blade at the expected molecular weight ranges for each pro- 
Immunostaining was performed. After 7 days in culture, 45 tein being probed. The samples were placed in the milk solu- 
samples were washed with PBS and fixed in 4% paraformal- 	 tion to block for a minimum of one hour. The primary anti- 
dehyde for 15 minutes at room temperature. Following fixa- 	 body was added according to the following dilutions: MAP2 
tion, the samples were washed 2x in PBS. A solution contain- 	 (1:500), Nestin (1:500), GAPDH (1:200), Actin (1:6000), 
ing 0.25% Triton-X 100, 1% bovine serum albumin and 10% 
	
MyoD (1:200), Myogenin (1:200) and GFAP (1:500). The 
goat serum was prepared in PBS. Samples were probed for 50 samples were incubated in the primary antibody overnight in 
primary antibodies including Vimentin (1:200. Sigma-Ald- 	 the cold room on a rocker. The samples were then washed 3x 
rich), F-Actin (1:50, Molecular Probes), TU71 (1:500, 	 with TBS containing 0.1% Tween 20 for 5-10 minutes each 
Covance), MAP2 (1:400, Sigma-Aldrich), and DAPI 	 wash. The secondary antibodies, Mouse-HRP (horseradish 
(1:5000, Molecular Probes) and allowed to incubate for 2 	 peroxidase) (1:5000, Novagen) and Rabbit-HRP (1:3000, 
hours at room temperature. The samples were washed 3x with 55 Biorad), were added to a 5% milk (Biorad) solution. The 
PBS and secondary antibodies of Alexa-Fluor conjugated 	 samples were incubated in the secondary antibodies for a 
goat anti-mouse (1:200) and goat anti-rabbit (1:200) were 	 minimum of one hour. The samples were then washed 3x with 
added and allowed to incubate for a minimum of 1 hour at 	 TBS containing 0.1% Tween 20 for 5-10 minutes each wash. 
room temperature covered with aluminum foil to protect them 	 Chemiluminescent Detection was performed. The anti- 
from light. The samples were washed 2x with PBS and 60 body detection solution was prepared by mixing component 
mounted to coverslips using Gel-mount (Invitrogen). The 	 A and B in a 40:1 ratio. The samples were prepared for 
samples were imaged using laser scanning confocal micros- 	 imaging by placing Saran wrap over a piece of cardboard and 
copy. 	 reassembling each membrane on the Saran wrap. The anti- 
Immunostaining results from examining the cells after 7 
	
body detection mixture was added to the membrane and 
days in culture on PVDF fibers stimulated with 9 mV/cm 65 allowed to incubate for 5 minutes in the dark. The detection 
direct current applied field indicate advanced differentiated 	 mixture was carefully blotted to remove any excess and Saran 
cell morphology by the presence of intermediate filament 	 wrap was placed over the top of each membrane. The mem- 
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brane was exposed to the camera without a filter for two time 
periods, 5 minutes and 10 minutes in the Alpha Innotech 
Fluorochem Imager. The data was analyzed using the 
A1phaEase F1uorChem software by normalizing the protein 
bands to the housekeeping protein GAPDH. 5 
Western blot analysis showed the expression of MAP2 (72 
kDa) protein in stimulated PVDF fibers. Protein content was 
quantified by normalizing to the housekeeping protein 
GAPDH. In comparison to the results obtained for CP2 and 
PVDF fibers there was much lower expression of MAP2 (72 io 
kDa) protein for both the CP2 and PVDF fibers compared to 
the PVDF stimulated fibers. 
In summary, culturing IrMSCs on an exemplary scaffold 
designed to provide electrical stimulation succeeded in dem-
onstrating the formation of an organized cytoskeleton. In 15 
contrast, Titushkin et al. reported that the application of 2 
V/cm direct current electrical stimuli to IrMSCs resulted in 
membrane detachment from the cytoskeleton. There are sev-
eral possible reasons for the differences observed. The field 
applied in our design was much lower at 9 mV/cm compared 20 
to Titushkin's. Furthermore, the field applied to the PVDF 
fibers was used by the PVDF fibers to stimulate the dipoles in 
its crystalline structure resulting in an indirect effect on the 
cells. One could think of this as the PVDF fibers enabling the 
conversion of the appliedvoltage to a mechanical strain on the 25 
fibers. Although this electric field was substantially lower 
than what is required to elicit a mechanical response in the 
PVDF at the macroscale, any movement in the molecular 
structure most likely can be felt by the cells due to their highly 
sensitive nature. 30 
The proliferation results indicate the stimulated PVDF 
fibers incorporated about 10% more EdU than the TCPS. 
Previous studies investigating the proliferation of IrMSCs 
when cultured on nanotopography show a decrease in the 
proliferation compared to TCPS due to the influence topo- 35 
graphical cues have on the differentiation of the cells. One 
explanation for our results may be due to the 3D architecture 
of the scaffold. The cells attached to the multiple layers had 
access to more surface area for proliferation compared to a 2D 
environment. A high seeding density may have also caused 40 
reduced proliferation in TCPS since hMSCs are contact 
inhibited cells, i.e. they stop dividing when they reach con-
fluence. 
The results obtained for protein expression indicate the 
stimulated PVDF fibers are producing MAP2 protein. IMMU- 45 
nontaining for this protein confirms the presence although at 
a low level. MAP2 has several isoforms associated with it 
resulting in expression at different molecular weights, 72 kDa 
(MAP2c), 100 kDa (MAP2d) and kDa (MAP2a). The PVDF 
stimulated fibers expressed a wide band at 72 kDa but no 50 
presence of the other isoforms was detected. This may indi-
cate the differentiation process is occurring at a much slower 
rate which correlates well with the enhanced proliferation 
observed. CP2 and PVDF fibers showed strong bands for the 
isoform at 100 kDa and all materials showed very weak or no 55 
presence at 239 kDa. The precise role of each isoform has 
been described by Kavallaris et al. as having distinct cellular 
functions. They explain that in the early stage of development 
and differentiation, lower molecular weight isoforms MAP2c 
and MAP2d form. The higher molecular weight isoforms, 60 
MAP2a and MAP2b, are found exclusively in dendrites of 
neuronal cells with MAP2a being the highest molecular 
weight found in late stage development and MAP2b present 
in embryonic and adult stages. MAP2d is expressed as alter-
native splicing of MAP2, is developmentally regulated and 65 
found in neuronal cell bodies. MAP2c has been expressed in 
dendrites, axons and glial cells and has been found to express  
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at high levels during early brain development. This isoform is 
typically replaced by higher molecular weight isoforms, how-
ever, it has been found to remain in the olfactory system and 
the retina. Since MAP2c is found in all cell compartments, it 
is necessary to determine the molecular weight correspond-
ing to the presence of MAP2 to associate the findings with its 
isoform to help understand the gene expression observed. The 
presence of several isoforms for the CP2 and PVDF fibers 
suggest the protein is being expressed in dendrites and the 
cells are assuming a neuronal lineage. 
Our results have shown the application of a direct current 
electric field to stimulate PVDF fibers during IrMSC culture 
to be promising. The incorporation of electrical stimuli in a 
3D scaffold by employing an electroactive polymer, such as 
PVDF, provides another level of stimuli during in vitro cul-
ture and brings us closer to mimicking in vivo conditions. 
All references, including publications, patent applications, 
and patents, cited herein are hereby incorporated by reference 
to the same extent as if each reference were individually and 
specifically indicated to be incorporated by reference and 
were set forth in its entirety herein. 
The use of the terms "a" and "an" and "the" and similar 
referents in the context of describing the invention (especially 
in the context of the following claims) are to be construed to 
cover both the singular and the plural, unless otherwise indi-
cated herein or clearly contradicted by context. The terms 
"comprising," "having," "including," and "containing" are to 
be construed as open-ended terms (i.e., meaning "including, 
but not limited to,") unless otherwise noted. Recitation of 
ranges of values herein are merely intended to serve as a 
shorthand method of referring individually to each separate 
value falling within the range, unless otherwise indicated 
herein, and each separate value is incorporated into the speci-
fication as if it were individually recited herein. All methods 
described herein can be performed in any suitable order 
unless otherwise indicated herein or otherwise clearly con-
tradicted by context. The use of any and all examples, or 
exemplary language (e.g., "such as") provided herein, is 
intended merely to better illuminate the invention and does 
not pose a limitation on the scope of the invention unless 
otherwise claimed. No language in the specification should be 
construed as indicating any non-claimed element as essential 
to the practice of the invention. 
Preferred embodiments of this invention are described 
herein, including the best mode known to the inventors for 
carrying out the invention. Variations of those preferred 
embodiments may become apparent to those of ordinary skill 
in the art upon reading the foregoing description. The inven-
tors expect skilled artisans to employ such variations as 
appropriate, and the inventors intend for the invention to be 
practiced otherwise than as specifically described herein. 
Accordingly, this invention includes all modifications and 
equivalents of the subject matter recited in the claims 
appended hereto as permitted by applicable law. Moreover, 
any combination of the above-described elements in all pos-
sible variations thereof is encompassed by the invention 
unless otherwise indicated herein or otherwise clearly con-
tradicted by context. 
The invention claimed is: 
1. An assembly configured to utilize stimuli through bio-
active fibers comprising: 
a first substrate film; 
a first electrode and a second electrode disposed on said 
first substrate film; and 
a layer that comprises a plurality of aligned, electro spun-
piezoelectric polymer fibers, 
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such that the layer of aligned, electrospun piezoelectric 
polymer fibers forms: 
• first outer periphery region configured to be connected 
to said first electrode; 
• second outer periphery region configured to be con-
nected to the second electrode; and 
an inner region that is suspended over a bottom surface 
between the first electrode and second electrode. 
2. The assembly of claim 1, wherein the layer is a first layer 
and the assembly comprises a second layer having a plurality 
of aligned, electrospun piezoelectric polymer fibers, 
such that the second layer forms: 
• first outer periphery region configured to be connected 
to a third electrode on a second substrate film; 
• second outer periphery region configured to be con-
nected to a fourth electrode on the second substrate 
film; and 
an inner region that is suspended over a bottom surface 
located between the third electrode and the fourth 
electrode; and 
the said second substrate film is layered on the first sub-
strate film in a configuration that permits electrical 
stimulation of the first layer independent of the second 
layer. 
3. The assembly of claim 2, wherein the first layer and the 
second layer are independently connected to individual volt-
age sources. 
4. The assembly of claim 1, wherein the plurality of 
aligned, electrospun piezoelectric polymer fibers of the layer 
comprises polyvinylidene fluoride (PVDF). 
5. The assembly of claim 1, further comprising human 
mesenchymal stem cells and effective cell culture media. 
6. The assembly of claim 1, further comprising induced 
pluripotent stem cells and effective cell culture media. 
7. The assembly of claim 1, further comprising embryonic 
stem cells and effective cell culture media. 
8. The assembly of claim 1, wherein the plurality of 
aligned, electrospun piezoelectric polymer fibers of layer are 
substantially parallel to one another. 
9. The assembly of claim 2, wherein the plurality of 
aligned, electrospun piezoelectric polymer fibers of the first 
layer are substantially parallel to one another, and wherein the 
plurality of aligned, electrospun piezoelectric polymer fibers 
of the second layer are substantially parallel to one another. 
10. The assembly of claim 1, wherein an electrical stimuli 
is applied to the comprising the plurality of aligned, electro-
spun piezoelectric polymer fibers. 
11. The assembly of claim 1, wherein said first substrate 
film is a pre-electroded substrate film, and wherein said first 
and second electrodes are configured to be deposited onto 
said first substrate film prior to attachment of said layer com-
prising the aligned, electrospun piezoelectric polymer fibers 
to said pre-electroded substrate film. 
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12. The assembly of claim 1, wherein said fibers are con-
nected to said first and second electrodes with a silicon adhe-
sive. 
13. The assembly of claim 1, wherein said first and second 
5 electrodes are comprised of gold. 
14. The assembly of claim 1, wherein said layer is porous. 
15. The assembly of claim 14, wherein the second layer is 
porous. 
16. A three dimensional scaffolding system configured to 
l0 transmit stimuli through fibers comprising: 
• first layer of aligned electrospun piezoelectric polymer 
fibers provided on a first substrate film; 
• second layer of aligned electrospun piezoelectric poly- 
15 	 mer fibers provided on a second substrate film; and 
an electrical stimulation system configured to selectively 
apply electrical stimulation to the first layer of fibers 
independently of the second layer of fibers, comprising: 
• first electrode and a second electrode disposed on the first 
20 substrate film configured to independently apply electri-
cal stimulation to the first layer by enabling the conver-
sion of the applied electrical stimulation to a mechanical 
strain on the fibers of the first layer on a molecular level 
without eliciting a mechanical response at a macroscale 
25 	 level; and 
• third electrode and a fourth electrode disposed on the 
second substrate film configured to independently apply 
electrical stimulation to the second layer by enabling the 
conversion of the applied electrical stimulation to a 
30 
mechanical strain on the fibers of the second layer on a 
molecular level without eliciting a mechanical response 
at a macroscale level. 
17. The three dimensional scaffolding system of claim 16, 
35 wherein the electrical stimulation system is configured to 
provide electrical stimulation at about 9 mV/cm. 
18. The three dimensional scaffolding system of claim 16, 
wherein the electrical stimulation system is configured to 
provide electrical stimulation below 10 mV/cm. 
40 	 19. An assembly configured to utilize stimuli through bio- 
active fibers comprising: 
• first substrate film; 
• first electrode and a second electrode disposed on said 
first substrate film; and 
45 	 a non-woven layer of aligned, electrospun piezoelectric 
polymer fibers having: 
• first outer periphery region configured to be connected 
to said first electrode; 
• second outer periphery region configured to be con-
50 	 nected to the second electrode; and 
an inner region that is suspended over a bottom surface 
between the first electrode and second electrode. 
